# An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint

> **NCT06485843** · PHASE2 · RECRUITING · sponsor: **Ageless Biotech, Inc.** · enrollment: 400 (estimated)

## Conditions studied

- Osteoarthritis
- Osteo Arthritis Knee

## Interventions

- **DRUG:** OA-SYS

## Key facts

- **NCT ID:** NCT06485843
- **Lead sponsor:** Ageless Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06485843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06485843, "An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06485843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*